Bernie Sanders wants to make Ozempic cheaper [Business Insider]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Business Insider
A recent study found that Ozempic can be made for less than $5 per month — but it costs nearly $1,000. Sen. Bernie Sanders is outraged by the price of Ozempic — so much that he wants to meet with the CEO of its maker, pharma giant Novo Nordisk, Bloomberg reports Sanders, who is considering hearings on the issue, wants to first talk to Novo chief Lars Fruergaard Jørgensen about cutting the list prices of GLP-1 drugs Ozempic and Wegovy, according to Bloomberg. Sanders — who chairs the Senate Health, Education, Labor, and Pensions (HELP) Committee — was responding to a new study by the medical journal JAMA Network published Wednesday, which found that Ozempic "can likely be manufactured for prices far below current prices, enabling wider access." "A new Yale study found that Ozempic costs less than $5 a month to manufacture," Sanders said in a statement . "And yet, Novo Nordisk charges Americans nearly $1,000 a month for this drug, while the same exact product can be purchased f
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk: Medicare Coverage To Unlock Another Big Market For Wegovy [Seeking Alpha]Seeking Alpha
- Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024 [Yahoo! Finance]Yahoo! Finance
- Novo Reigns, Stellantis Resilient: EMEA Earnings Week Ahead [Yahoo! Finance]Yahoo! Finance
- Novo Reigns, Stellantis Resilient: EMEA Earnings Week Ahead [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Novo Reigns, Stellantis Resilient: EMEA Earnings Week Ahead [BNN Bloomberg (Canada)]BNN Bloomberg
NVO
Earnings
- 11/3/23 - Beat
NVO
Sec Filings
- 4/26/24 - Form 6-K
- 4/25/24 - Form 6-K
- 4/25/24 - Form 6-K
- NVO's page on the SEC website